Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-04-25 Sale | 2023-04-26 4:12 pm | Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer | 509 | $16.29 | $8,292 | 350,151 (Direct) | View |
| 2023-04-25 Sale | 2023-04-26 4:08 pm | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer | 2,633 | $16.29 | $42,892 | 330,691 (Direct) | View |
| 2023-04-18 Sale | 2023-04-19 4:15 pm | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 3,423 | $15.27 | $52,269 | 352,588 (Direct) | View |
| 2023-04-18 Sale | 2023-04-19 4:12 pm | Immunovant Inc. | IMVT | Butchko Julia G. Chief Development Officer | 1,544 | $15.27 | $23,577 | 430,063 (Direct) | View |
| 2023-04-18 Sale | 2023-04-19 4:09 pm | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 3,395 | $15.27 | $51,842 | 1,234,369 (Direct) | View |
| 2023-02-02 Sale | 2023-02-03 07:24 am | Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer | 537 | $18.24 | $9,795 | 262,996 (Direct) | View |
| 2023-01-26 Sale | 2023-01-27 07:20 am | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer | 10,156 | $18.51 | $187,988 | 245,660 (Direct) | View |
| 2023-01-11 Sale | 2023-01-13 08:21 am | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 4,021 | $16.8 | $67,553 | 993,932 (Direct) | View |
| 2023-01-11 Sale | 2023-01-13 08:19 am | Immunovant Inc. | IMVT | Butchko Julia G. Chief Dev. & Tech. Officer | 60,490 | $16.79 | $1,015,596 | 331,419 (Direct) | View |
| 2023-01-11 Sale | 2023-01-13 08:16 am | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 4,510 | $16.75 | $75,525 | 268,347 (Direct) | View |
| 2023-01-11 Sale | 2023-01-13 08:13 am | Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer | 44,568 | $16.75 | $746,317 | 263,533 (Direct) | View |
| 2022-10-21 Sale | 2022-10-25 07:43 am | Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer | 341 | $9.67 | $3,297 | 308,101 (Direct) | View |
| 2022-10-13 Sale | 2022-10-17 08:59 am | Immunovant Inc. | IMVT | Butchko Julia G. Chief Dev. & Tech. Officer | 928 | $9.18 | $8,519 | 391,909 (Direct) | View |
| 2022-10-13 Sale | 2022-10-17 08:57 am | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 2,793 | $9.18 | $25,640 | 997,953 (Direct) | View |
| 2022-10-11 Sale | 2022-10-13 4:20 pm | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 12,500 | $9.44 | $118,000 | 272,857 (Direct) | View |
| 2022-10-06 Purchase | 2022-10-07 4:32 pm | Immunovant Inc. | IMVT | Roivant Sciences Ltd. 10% Owner | 416,667 | $6 | $2,500,002 | 73,805,331 (Direct) | View |
| 2022-09-30 Purchase | 2022-10-04 4:27 pm | Immunovant Inc. | IMVT | Pande Atul Director | 15,000 | $5.6 | $84,000 | 102,985 (Indirect Direct) | View |
| 2022-09-28 Sale | 2022-09-29 5:09 pm | Immunovant Inc. | IMVT | Butchko Julia G. Chief Dev. & Tech. Officer | 535 | $4.67 | $2,498 | 392,837 (Direct) | View |
| 2022-09-28 Sale | 2022-09-29 5:06 pm | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 1,605 | $4.67 | $7,495 | 1,000,746 (Direct) | View |
| 2022-09-29 Purchase | 2022-09-29 4:21 pm | Immunovant Inc. | IMVT | Torti Frank Director | 20,000 | $5.81 | $116,200 | 393,358 (Direct) | View |
| 2022-08-30 Sale | 2022-09-01 07:36 am | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 1,644 | $5.83 | $9,585 | 1,002,351 (Direct) | View |
| 2022-08-30 Sale | 2022-09-01 07:33 am | Immunovant Inc. | IMVT | Butchko Julia G. Chief Dev. & Tech. Officer | 548 | $5.83 | $3,195 | 393,372 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-04-17 Option Award | 2023-04-19 4:23 pm | N/A 2033-04-17 | Immunovant Inc. | IMVT | Stout Jay S Chief Technology Officer | 250,000 | $0 | 250,000 (Direct) | View |
| 2023-04-12 Option Award | 2023-04-14 4:37 pm | N/A 2033-04-12 | Immunovant Inc. | IMVT | Pande Atul Director | 28,783 | $0 | 131,768 (Direct) | View |
| 2023-04-12 Option Award | 2023-04-14 4:35 pm | N/A 2033-04-12 | Immunovant Inc. | IMVT | Hughes Douglas J. Director | 28,783 | $0 | 130,015 (Direct) | View |
| 2023-04-12 Option Award | 2023-04-14 4:33 pm | N/A 2033-04-12 | Immunovant Inc. | IMVT | Fromkin Andrew J. Director | 28,783 | $0 | 117,268 (Direct) | View |
| 2023-04-12 Option Award | 2023-04-14 4:31 pm | N/A 2033-04-12 | Immunovant Inc. | IMVT | MIGAUSKY GEORGE V Director | 28,783 | $0 | 138,768 (Direct) | View |
| 2023-04-12 Option Award | 2023-04-14 4:29 pm | N/A 2033-04-12 | Immunovant Inc. | IMVT | Torti Frank Director | 280,208 | $0 | 673,566 (Direct) | View |
| 2023-04-12 Option Award | 2023-04-14 4:26 pm | N/A 2033-04-12 | Immunovant Inc. | IMVT | Butchko Julia G. Chief Dev. & Tech. Officer | 230,269 | $0 | 561,688 (Direct) | View |
| 2023-04-12 Option Award | 2023-04-14 4:24 pm | N/A 2033-04-12 | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer | 201,485 | $0 | 447,145 (Direct) | View |
| 2023-04-12 Option Award | 2023-04-14 4:22 pm | N/A 2033-04-12 | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 201,485 | $0 | 469,832 (Direct) | View |
| 2023-04-12 Option Award | 2023-04-14 4:19 pm | N/A 2033-04-12 | Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer | 201,485 | $0 | 464,481 (Direct) | View |
| 2023-04-12 Option Award | 2023-04-14 4:14 pm | N/A 2033-04-12 | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 560,417 | $0 | 1,554,349 (Direct) | View |
| 2022-08-17 Option Award | 2022-08-19 4:57 pm | N/A 2032-08-17 | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer | 282,464 | $0 | 425,464 (Direct) | View |
| 2022-08-17 Option Award | 2022-08-19 4:56 pm | N/A 2032-08-17 | Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer | 282,464 | $0 | 478,090 (Direct) | View |
| 2022-08-17 Option Award | 2022-08-19 4:54 pm | N/A 2032-08-17 | Immunovant Inc. | IMVT | Butchko Julia G. Chief Dev. & Tech. Officer | 282,464 | $0 | 563,568 (Direct) | View |
| 2022-08-17 Option Award | 2022-08-19 4:52 pm | N/A 2032-08-17 | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 282,464 | $0 | 455,005 (Direct) | View |
| 2022-08-17 Option Award | 2022-08-19 4:50 pm | N/A 2032-08-17 | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 1,129,856 | $0 | 1,682,587 (Direct) | View |
| 2022-08-17 Option Award | 2022-08-19 4:48 pm | N/A 2032-08-17 | Immunovant Inc. | IMVT | Fromkin Andrew J. Director | 52,727 | $0 | 120,153 (Direct) | View |